arrow
D

Dattatraya Patil

Emory University
H指数:25
被引数:2,235

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

An increase in splenic volume after first-line immunotherapy is associated with worse PFS in patients with metastatic renal cell carcinoma

一线免疫治疗后脾脏体积增大与转移性肾细胞癌患者无进展生存期较差相关

2026-02-010
PRE
Racial and Demographic Variables Are Associated with Accurate 24-hour Urine Collection Completion and Results

种族和人口统计变量与准确24小时尿液收集完成情况和结果相关

2026-02-010
PRE
Comparative prognostic performance of KEYNOTE-564 and AUA risk stratification in nonmetastatic clear cell renal cell carcinoma

非转移性透明细胞肾细胞癌中KEYNOTE-564与AUA风险分层的比较预后性能

2026-01-010
PRE
Predictors of Survival and Recurrence After Partial or Radical Nephrectomy in Women with Localized Renal Cell Carcinoma: A Multicenter Analysis

局部肾细胞癌女性患者行部分或根治性肾切除术后的生存与复发预测因素:一项多中心分析

2026-01-010
PRE
Single-port Robotic Retroperitoneal Partial Nephrectomy via Low Anterior Access: A Propensity-matched Comparative Analysis to Standard Transperitoneal Multiport Robotic Surgery from the Single Port Advanced Research Consortium (SPARC)
2025-12-220
PRE
Association of Elevated Neutrophil-to-Lymphocyte, Platelet-to-Lymphocyte, and De Ritis Ratios With Major Complications After Surgery for Renal Cell Carcinoma: A Pathway to Optimize Charlson Comorbidity Index and Preoperative Predictive Modeling

升高的中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值以及De Ritis比值与肾细胞癌术后主要并发症的关联:优化Charlson合并症指数和术前预测模型的一条途径

2025-11-011
PRE
Impact of Hemoglobin A1c on the Obesity Paradox and Survival in Patients With Non-Metastatic Renal Cell Carcinoma

糖化血红蛋白(Hemoglobin A1c)对非转移性肾细胞癌患者肥胖悖论及生存的影响

2025-11-010
PRE
Proposed tripartite classification of T1 renal cell carcinoma: Comparison with current binary system

T1肾细胞癌的三元分类法提案:与当前二元系统的比较

2025-11-010
PRE
Computational Histology Artificial Intelligence (CHAI) Enhances Risk Stratification of High-grade Ta Non–muscle-invasive Bladder Cancer in a Multicenter Cohort: Comparison to Current European Association of Urology and American Urological Association Stratification Schemes

计算组织学人工智能(CHAI)在多中心队列中增强了高级别Ta非肌肉浸润性膀胱癌的风险分层:与当前欧洲泌尿外科学会和美國泌尿外科学会分层方案的比较

2025-06-120
PRE
DIFFERENTIAL IMPACT OF POSITIVE SURGICAL MARGIN IN HIGH-RISK LOCALIZED RENAL CELL CARCINOMA AFTER ADJUVANT AND NEOADJUVANT SYSTEMIC THERAPY: A MULTICENTER ANALYSIS
2024-05-010
PRE
A PROPENSITY SCORE-MATCHED ANALYSIS OF OUTCOMES OF NEOADJUVANT AND ADJUVANT SYSTEMIC THERAPY IN HIGH-RISK LOCALIZED RENAL CELL CARCINOMA: IMPACT OF TIMING OF THERAPY AND POSITIVE MARGIN
2024-05-010
PRE